#United States #St. Louis #Colorectal Cancer #ColoSense #Geneoscopy

Enhancing Colorectal Cancer Screening: Geneoscopy's Innovative ColoSense NextStep

Geneoscopy, a pioneering healthcare diagnostics firm, has taken a significant stride in colorectal cancer prevention with the introduction of its latest initiative, ColoSense NextStep. This comprehensive navigation program is designed to support patients who have received a positive result from the ColoSense colorectal cancer screening test, providing essential guidance towards the necessary follow-up colonoscopy.

The statistics surrounding follow-up colonoscopies post-screening results are concerning. In a thorough examination of nearly 33,000 individuals who had positive stool-based screening results, it was found that a mere 56% proceeded with the recommended follow-up colonoscopy within a year. This alarming trend highlights a critical gap in colorectal cancer screening processes, as not completing the follow-up can lead to serious repercussions, including a doubling of the risk of mortality from colorectal cancer.

Understanding ColoSense NextStep

ColoSense NextStep isn't just about procedure; it is a holistic approach to patient care. By aiming to guide patients swiftly towards completing their screenings, Geneoscopy’s program recognizes the emotional and logistical hurdles individuals may face after a positive diagnosis.

Dr. Erica Barnell, co-founder and Chief Science and Medical Officer at Geneoscopy, emphasizes the emotional weight that accompanies a positive screening result. Many patients often feel confused and anxious about their next steps, and ColoSense NextStep is geared towards alleviating that distress. The program promises to provide personalized support designed to help patients understand the implications of their screening result and the importance of immediate follow-up care.

The initiative empowers health providers by equipping them with another resource to assist their patients. When providers opt into the program, participating patients receive outreach through various channels—be it text, email, or phone calls—from a dedicated Clinical Support Team. This team delivers educational insights about the importance of follow-up colonoscopies, addressing any questions, and identifying barriers that might hinder patients from accessing further care.

The Importance of Timely Follow-Up

The goal for ColoSense NextStep is clear: to ensure patients undergo their follow-up colonoscopy within 90 days after a positive screening result. This proactive approach is intended to close the loop on colorectal cancer screening, allowing healthcare providers and patients to work together towards successful outcomes.

By tackling common obstacles, such as transportation challenges or navigating healthcare systems, this program not only seeks to enhance the patient experience but also aims to boost compliance rates for follow-up screenings. Addressing these barriers is paramount in fostering an environment where patients feel supported, encouraged, and informed about their health decisions.

Andrew Barnell, co-founder and CEO of Geneoscopy, shares that successful colorectal cancer screening programs should go beyond just the initial testing. The timely execution of follow-up procedures is vital to realize the full benefits of colorectal cancer screenings. ColoSense NextStep fills this gap by enabling healthcare professionals to extend their support to patients after screening results, promoting a more involved and patient-centered approach to healthcare.

A Step Forward in Cancer Prevention

The launch of ColoSense NextStep underscores Geneoscopy's unwavering commitment to making colorectal cancer screening accessible and effective. As a provider-enabled and opt-in service, participants retain control and voluntarily engage with the program, which operates with strict adherence to privacy standards and patient consent.

Overall, ColoSense NextStep represents an innovative step forward in the realm of colorectal health, illustrating how targeted support mechanisms can enhance patient adherence to crucial follow-up care. For more information about this initiative, visit colosense.com/colosense-nextstep.

As colorectal cancer remains a leading cause of cancer-related deaths, initiatives such as these can save lives by ensuring that necessary follow-up actions are both manageable and fruitful, ultimately steering patients towards healthier futures.